Kristen Peterson, PharmD, BCOP, reviews pharmacists’ pivotal role in optimizing patient transitions between inpatient and outpatient care settings to ensure treatment continuity and medication management in multiple myeloma care.
Pharmacists discuss the impact and alternatives amidst red blood cell shortages in myelofibrosis, highlighting challenges, patient outcomes, quality of life issues, and healthcare cost implications.
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, and a panel of pharmacists exploring explore pharmacist roles in myelofibrosis care, treatment challenges, patient outcomes, and pharmacist responsibilities within interdisciplinary teams.